Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: Evidence-based clinical science should guide FDA decision making about product labeling

Bibliographische Detailangaben

Veröffentlicht in:	Contraception (Stoneham) 2006-05, Vol.73 (5), p.440-442
Hauptverfasser:	Shulman, Lee P., Bateman, Louise H., Creinin, Mitchell D., Cullins, Vanessa E., Doyle, Lee Lee, Godfrey, Emily, Murphy, Patricia, Rodriguez, Pablo, Spear, Scott J., Stewart, Felicia H., Thomas, Michael A., Westhoff, Carolyn L., Worthington, Sandra
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Communication Contraceptive Agents, Female Drug Labeling - standards Evidence-Based Medicine Female Humans United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!